A carregar...
Neoadjuvant docetaxel with or without carboplatin plus dual HER2 blockade for HER2-positive breast cancer: a retrospective multi-center Chinese study
BACKGROUND: This study aimed to compare the real-world efficacy and safety of the TCbHP regimen (docetaxel, carboplatin, trastuzumab and pertuzumab) and the THP regimen (docetaxel, trastuzumab and pertuzumab) as neoadjuvant therapy for Chinese patients with human epidermal growth factor receptor 2 (...
Na minha lista:
| Publicado no: | Gland Surg |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
AME Publishing Company
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7804556/ https://ncbi.nlm.nih.gov/pubmed/33447559 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/gs-20-791 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|